{
  "docId": "019de076-b7ca-70fb-95b8-5a74e3aefffe",
  "docSlug": "5062b9a9257606648ea145bccd66e04d",
  "documentTitle": "Nuvalent | Investor Presentation Deck | 41 slides",
  "authorId": "nuvalent",
  "authorName": "Nuvalent",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 13,
  "pageCount": 41,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "customer_journey",
  "function": "frame_problem",
  "density": "dense",
  "nDataPoints": 10,
  "notes": "The slide uses a timeline-based customer journey framework to map clinical progression against therapeutic limitations.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-b7ca-70fb-95b8-5a74e3aefffe/13",
  "deckHref": "/decks/019de076-b7ca-70fb-95b8-5a74e3aefffe",
  "deckJsonHref": "/decks/019de076-b7ca-70fb-95b8-5a74e3aefffe.json",
  "deckAnchorHref": "/decks/019de076-b7ca-70fb-95b8-5a74e3aefffe#slide-13",
  "components": [
    {
      "bbox": {
        "h": 0.115,
        "w": 0.695,
        "x": 0.056,
        "y": 0.175
      },
      "kind": "diagram",
      "text": "1L, 2L, 3L+ progression timeline",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6495429e-e5ef-4cf5-8c5c-cbc60986e832",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.88,
        "w": 0.24,
        "x": 0.76,
        "y": 0.12
      },
      "kind": "image",
      "text": "Illustrative patient image",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7b951d33-07c5-410a-9428-359abf1a2efa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.285,
        "w": 0.695,
        "x": 0.056,
        "y": 0.535
      },
      "kind": "list",
      "text": "Key limitations including resistance mutations, brain penetrance, and adverse events",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0654c8a9-ca3f-4fdc-926b-97503b8cf82e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.185,
        "w": 0.695,
        "x": 0.056,
        "y": 0.325
      },
      "kind": "list",
      "text": "Standard of care details for 1L, 2L, and 3L+",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e360f556-174a-4cfc-bae5-185688cdd5a2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.695,
        "x": 0.056,
        "y": 0.85
      },
      "kind": "source-note",
      "text": "Sources: [1] Kwak E. et al., NEJM 2010... [13] Shiba-Ishii et al., Nature Cancer 2022.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a8c2e7f3-93b1-428f-b66f-19c2e8e2bead",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.485,
        "x": 0.106,
        "y": 0.088
      },
      "kind": "title",
      "text": "ALK+ NSCLC Patient Journey",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "12e9a5e2-40fc-4a2e-b682-5866dedd134b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Customer journey map",
      "slug": "customer-journey-map",
      "agent": null,
      "layer": "slide",
      "matchId": "bbb561ca-8562-4a87-918f-e0dd885b336e",
      "evidence": "ALK+ NSCLC Patient Journey",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "customer-journey-map",
      "slug": null,
      "matchId": "d65aa146-4ffd-4955-b6fe-1593cb696133",
      "evidence": "The slide maps the clinical progression of patients through lines of therapy (1L, 2L, 3L+).",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 14,
      "from": 12,
      "name": "Mece Breakdown",
      "slug": "40-mece-breakdown",
      "bestFor": "Problem structuring, ensuring completeness, strategic analysis",
      "matchId": "2ad14173-59a5-409e-9eff-4f8d228ecb07",
      "evidence": "The document presents a detailed breakdown of Nuvalent's therapies, including their innovative approach and promising clinical trial results.",
      "position": 1,
      "objective": "How do Nuvalent's therapies address the needs of patients with cancer?",
      "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage",
      "confidence": 0.7,
      "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}